Oxford Cancer

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Found 1145 matches for

Polygenic risk scores

Choosing the right diagnostic test to improve the patient experience

Development of multi-cancer tests and studying early cancer biology

Early intervention trials

Universal consent at the Oxford University Hospitals (OUH) Translational Gastroenterology Unit

Integrating molecular diagnostics to predict progression from monoclonal gammopathy of undetermined significance (MGUS) to myeloma and intercept & treat individuals at highest risk

Factors determining ovarian cancer risk

Assessing risk of cancer using GP patient records

Activation of tumour infiltrating B cells

Determination of the relative importance of T-cell intrinsic and extrinsic factors in immune escape

Identification of cancer epitope targets

Reducing systemic dose whilst enhancing efficacy

Determining the molecular basis for the relationship between IT efficacy and toxicity

Comprehensive characterisation of shared immune mechanisms in organ-specific checkpoint induced and spontaneous autoinflammation

Optimising TIME for radiotherapy response

Remodelling the tissue immune microenvironment (TIME) during tumour development

Understanding prostate cancer progression

Developing intelligent image-based predictors of GI & lung cancer risk

Application of topological data analysis to clinical trials

The Million Women Study